Qube Research & Technologies Ltd
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,889,940
+$17,138,086 QoQ
Shares Held
922,166
+85.1% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 331 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in SUPN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,889,940 | 922,166 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,751,854 | 498,198 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,498,348 | 311,838 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,931,838 | 124,123 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,240,459 | 229,710 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,212,054 | 98,078 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,354,377 | 65,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,148,057 | 100,964 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,284,600 | 160,172 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $327,558 | 9,603 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,729,765 | 94,325 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $1,783,099 | 59,318 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,678,390 | 46,326 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,147,682 | 32,175 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $520,240 | 15,369 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $1,509,030 | 51,750 | Shares | Sole | 2022-02-10 | |
| 2020-06-30 | $248,757 | 10,474 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $192,475 | 10,699 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||